Would you perform surgery after only reading about it? Trading live on an untested idea is the same wager. Backtesting, rehearsing your exact rules against historical price, is how an idea earns the right to touch money.
Manual replay beats fantasy scrolling
Scrolling a finished chart and cherry-picking wins is not testing; hindsight marks every exam. Use bar-replay (TradingView has it): hide the future, step candle by candle, and log every decision as if live: entry, stop, target, and the confluences present, written before advancing. Slow is the feature: your eyes learn the setup while the sample builds.
The honesty rules
- Define rules first, in writing: testing "vibes" produces vibes.
- Take every qualifying setup, including ugly ones; skipping in-sample losers is self-deception with extra steps.
- Charge costs: subtract realistic spread from each result; scalping ideas regularly die at this step alone.
- Log in R so results feed straight into an expectancy calculation.
- One market, one timeframe per test: isolate the variable.
What a sample proves, and doesn't
Fifty to a hundred replayed trades showing positive expectancy proves the idea deserved a demo trial, not that it's holy. Markets shift; live spreads bite; your live psychology differs from replay calm. The pipeline is: backtest → demo (30+ compliant trades) → small live. Each stage filters; most ideas rightly die early, which is the cheapest place for them to die.
Rehearsal is respect for your capital. The market charges full tuition to everyone who skips it.
Education only, not financial advice. Trading carries risk of loss; never trade money you cannot afford to lose.
